Chronic diseases can be prevented by reducing risk factors related to high blood pressure, consumption of tobacco and/or alcohol, hyperglycaemia, stress factors, obesity, etc. These risk factors are mostly linked to unhealthy sedentary lifestyles of chronic disease patients, and could be successfully modified by using appropriate health practices. In line with this, a relevant number of programmes have shown evidence on their positive impact on chronic conditions prevention and management, but there is scarcity of data on the efficiency and cost-benefit of these programmes. This lack of data reduces, in some cases, the policy engagement and support to these programmes, but most important, it prevents health systems from being more sustainable and efficient. On the other hand, socio-economic factors have also been demonstrated to be extremely relevant health determinants. This project goes beyond the current state of the art by providing cost-efficiency evidence data of chronic prevention and management evidenced-based programmes, while integrating social determinants of health as part of the recruitment and engagement of individuals in the research methodology.
The project EFFICHRONIC aims to provide evidence on the positive return of investment and cost-efficiency of the application of the Chronic Disease Self-Management Programme (CDSMP) in 5 different European countries (France, Italy, The Netherlands, Spain and UK) with a particular focus on the health, medical, social, cultural and economic factors linked with a higher burden of chronic disorders in Europe.
The specific objectives of EFFICHRONIC are:
- To carry out a multidimensional analysis and develop stratification methodologies to identify vulnerable groups/individuals in the 5 countries/regions involved.
- To design specific strategies to reach the targeted individual/groups in order to involve them in the implementation programme.
- To implement the programme in the 5 regions/countries, including the appropriate actions to involve at least 400 individuals of the stratified/identified populations in each setting (N=2000).
- To generate a comprehensive framework for the impact assessment of the intervention programme through cost-efficiency and health economic analysis.
- To develop policy recommendations and best practices based on the results of EFFICHRONIC.